Skip to main content

TikkunLev Therapeutics

TIKKUNLEV Therapeutics develops precision medicine programs focused on cardiovascular disease. The company's primary goal is to repair failing heart muscle at the biological level. This approach aims to reverse the progression of heart failure in patients.

Traction –/10
HQ unknown
2200+ followers
  • Biotechnology
Updated 5 months ago

Funding

Funding rounds are not available yet.

Founders

1 founder

Robin Shaw

Co-Founder

Product

Features

  • TIKKUNLEV Therapeutics develops precision medicine programs focused on cardiovascular disease. The company's primary goal is to repair failing heart muscle at the biological level. This approach aims to reverse the progression of heart failure in patients.
This profile is AI-generated and may contain inaccuracies.